Part B Drug Payment Reform: Lower Expenditures Without Signs of Adverse Effects

Jeffrey Ballou, Arnold Chen, Valerie Cheh, Deo Bencio, Bonnie Hart, Joshua Parks and John Hall

Mathematica Policy Research Reports from Mathematica Policy Research

Abstract: Research found that physicians were being reimbursed far in excess of what they were paying for Part B drugs and that there was little incentive in the Medicare payment system to contain drug expenditures.

Keywords: Medicare; payment reform; drugs and biologicals; Health (search for similar items in EconPapers)
Pages: 177
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.cms.gov/reports/downloads/Cheh_PartB_2009.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:mpr:mprres:823823ccc9f840baa6a6c802d2824f0f

Access Statistics for this paper

More papers in Mathematica Policy Research Reports from Mathematica Policy Research Mathematica Policy Research P.O. Box 2393 Princeton, NJ 08543-2393 Attn: Communications. Contact information at EDIRC.
Bibliographic data for series maintained by Joanne Pfleiderer () and Cindy George ( this e-mail address is bad, please contact ).